BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
BioStem Technologies (OTC: BSEM) announced it purchased a four-acre parcel at the Research Park at Florida Atlantic University in Boca Raton to serve as its future headquarters for administrative offices, manufacturing, and distribution.
The City approved up to $300,000 in economic incentives tied to the creation of up to 100 jobs over five years. The company has not set a timetable for relocation. BioStem highlights its FDA-registered, AATB-accredited manufacturing site in Pompano Beach and its placental-derived wound-care product portfolio, including AmnioWrap 2 and VENDAJE brands.
BioStem Technologies (OTC: BSEM) ha annunciato di aver acquistato un terreno di four-acre nel Research Park presso la Florida Atlantic University a Boca Raton per fungere da futura sede centrale per uffici amministrativi, produzione e distribuzione.
La Città ha approvato incentivi economici fino a $300,000 legati alla creazione di fino a 100 posti di lavoro su cinque anni. L'azienda non ha fissato un calendario per il trasferimento. BioStem evidenzia il suo sito di produzione registrato FDA e accreditato dall'AATB a Pompano Beach e il suo portafoglio di prodotti per la cura delle ferite derivati dalla placenta, inclusi i marchi AmnioWrap 2 e VENDAJE.
BioStem Technologies (OTC: BSEM) anunció que adquirió una parcela de cuatro acres en el Research Park de la Florida Atlantic University en Boca Raton para servir como su futura sede central para oficinas administrativas, fabricación y distribución.
La ciudad aprobó hasta $300,000 en incentivos económicos vinculados a la creación de hasta 100 empleos en cinco años. La empresa no ha fijado un calendario para la reubicación. BioStem destaca su sitio de fabricación registrado por la FDA y acreditado por la AATB en Pompano Beach y su cartera de productos para el cuidado de heridas derivados de la placenta, incluidos AmnioWrap 2 y las marcas VENDAJE.
BioStem Technologies (OTC: BSEM)는 Boca Raton에 있는 Florida Atlantic University 연구 파크에서 행정 사무, 제조 및 유통을 위한 향후 본사로 사용할 4에이커 규모의 토지 하나를 매입했다고 발표했다.
도시는 최대 $300,000의 경제적 인센티브를 5년 동안 최대 100개의 일자리 창출에 연계해 승인했다. 회사는 이전 일정은 정하지 않았다. BioStem은 Pompano Beach에 위치한 FDA 등록, AATB 인증 제조 시설과 태반 유래의 창상 관리 포트폴리오(AmnioWrap 2 및 VENDAJE 브랜드 포함)를 강조한다.
BioStem Technologies (OTC : BSEM) a annoncé avoir acheté un terrain de quatre acres au Research Park de Florida Atlantic University à Boca Raton pour servir de futur siège social pour les bureaux administratifs, la fabrication et la distribution.
La ville a approuvé jusqu'à 300 000 $ d'incitations économiques liées à la création de jusqu'à 100 emplois sur cinq ans. L'entreprise n'a pas fixé de calendrier pour le déménagement. BioStem met en avant son site de fabrication enregistré par la FDA et accrédité par l'AATB à Pompano Beach et son portefeuille de produits de soins des plaies dérivés du placenta, y compris les marques AmnioWrap 2 et VENDAJE.
BioStem Technologies (OTC: BSEM) gab bekannt, dass es ein vier Acre großes Grundstück im Research Park der Florida Atlantic University in Boca Raton erworben hat, das als zukünftige Hauptverwaltung für Verwaltungsbüros, Herstellung und Vertrieb dienen soll.
Die Stadt hat bis zu $300,000 an wirtschaftlichen Anreizen genehmigt, verbunden mit der Schaffung von bis zu 100 Arbeitsplätzen über fünf Jahre. Das Unternehmen hat keinen Zeitplan für den Umzug festgelegt. BioStem hebt seinen FDA-registrierten, von der AATB anerkannten Herstellungsstandort in Pompano Beach sowie sein placenta-basiertes Wundheilportfolio hervor, einschließlich der Marken AmnioWrap 2 und VENDAJE.
BioStem Technologies (OTC: BSEM) أعلنت أنها اشترت قطعة أرض تبلغ مساحتها أربعة أفدنة في أبحاث بارك بجامعة فلوريدا أتلانتك في بوكا راتون لتكون مقرها المستقبلي للمكاتب الإدارية والتصنيع والتوزيع.
وافقت المدينة على ما يصل إلى $300,000 من الحوافز الاقتصادية المرتبطة بخلق حتى 100 وظيفة خلال خمس سنوات.
لم تحدد الشركة جدولا زمنيا للانتقال. تسلط BioStem الضوء على موقع التصنيع المسجل لدى FDA والمعتمد من AATB في بومبانو بيتش ومحفظة منتجات العناية بالجروح المستمدة من المشيمة، بما في ذلك علامتا AmnioWrap 2 و VENDAJE.
- Land purchase of four acres at FAU Research Park
- City approved up to $300,000 in economic incentives
- Plan to create up to 100 jobs over five years
- Maintains FDA-registered and AATB-accredited manufacturing site
- No relocation timetable set for the new headquarters
Future Relocation and Expansion to Create Up to 100 New Jobs Over 5 Years
City Approves Up to
POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the purchase of land for its future headquarters in the Research Park at Florida Atlantic University® in Boca Raton.
Under the terms of an agreement with the City, the Company will receive up to
“As we contemplate the long-term vision for BioStem, we anticipate the need to expand our operations in support of the growing demand for our advanced wound care products. Securing land at the Research Park provides the space for a centralized headquarters, access to talent and technology and attractive economic incentives,” said Jason Matuszewski, Chairman and CEO of BioStem Technologies. “While opportunities were presented to us by representatives of other states, we knew from the start that we wanted to remain in South Florida and continue to contribute greatly to the overall growth of the local life science industry. The Research Park location will place us among other technology innovators and in close proximity to a university with leading science and healthcare programs from which we can attract and train our highly specialized workforce. Furthermore, the City of Boca Raton has worked closely with us to understand and enable us to meet our real estate needs.”
The Research Park at Florida Atlantic University is home to technology companies and research-based organizations, serving as a hub for collaboration by connecting industry leaders and researchers, driving innovation and economic growth across South Florida. The location hosts Global Ventures, an international soft-landing center for second-stage technology companies as they expand into the U.S. market. Spanning 70 acres, the Research Park provides an environment where R&D companies can grow through access to university talent, state-of-the-art facilities, and tailored insights. Established in 1985, it is widely regarded as South Florida’s laboratory for new entrepreneurial ideas and technologies.
“The addition of BioStem Technologies to the Research Park’s community of innovation demonstrates the importance of our university research park for successful economic growth and long-term prosperity for South Florida,” said Andrew S. Duffell, president of the Research Park at Florida Atlantic. “The ability to collaborate with peer scientists close-by and to offer training opportunities for students an essential factor in developing a sustainable MedTech industry here.”
About BioStem Technologies:
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain ® processing method. BioRetain ® has been developed by applying the latest research in advanced wound care, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies’ quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks (“AATB”). These systems and procedures are established per current Good Tissue Practices (“cGTP”) and current Good Manufacturing Processes (“cGMP”). Our portfolio of quality brands includes AmnioWrap 2 ™, VENDAJE ®, VENDAJE AC ®, and VENDAJE OPTIC ®. Each BioStem Technologies placental allograft is processed at the Company’s FDA registered and AATB accredited site in Pompano Beach, Florida.
For more information visit biostemtechnologies.com and follow us on X and LinkedIn. To follow the latest developments at BioStem, sign up for the Company’s email distribution list HERE.
Investor Contact:
Philip Trip Taylor, Principal
Gilmartin Group
philip@gilmartinir.com
415-937-5406
Media Contact:
David Schull, President
Russo Partners
david.schull@russopartnersllc.com
858-717-2310
FAQ
What did BioStem (BSEM) announce on November 5, 2025?
How much economic incentive did Boca Raton approve for BioStem (BSEM)?
How many jobs will BioStem (BSEM) create and over what timeline?
Will BioStem (BSEM) move immediately to the FAU Research Park site?
What operations will be located at the new BioStem (BSEM) headquarters?
Does BioStem (BSEM) have accredited manufacturing already?
